References

References

1. Bayoumi AM, Zaric GS. The cost-effectiveness of Vancouver's supervised injection facility. CMAJ. 2008;179(11):11431151. Crossref, MedlineGoogle Scholar
2. Gray RH, Wawer MJ, Brookmeyer R, et al.. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):11491153. Crossref, MedlineGoogle Scholar
3. Centers for Disease Control and Prevention. CDC HIV/AIDS. Atlanta, GA: Department of Health and Human Services; 2009. Google Scholar
4. Donoghoe M, Verster A, Mathers B. WHO, UNODC, UNAIDS Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users. Geneva: World Health Organization; 2009. Google Scholar
5. Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, Prins M. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS. 2006;20(13):17711775. Crossref, MedlineGoogle Scholar
6. van den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Amsterdam cohort. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102(9):14541462. Crossref, MedlineGoogle Scholar
7. Ouellet L, Huo D. Declines in HIV prevalence and incidence among injection drug users in Chicago, 1988–2007. In: 2009 National HIV Prevention Conference; Atlanta, GA. Google Scholar
8. Edlin BR, Irwin KL, Faruque S, et al.. Intersecting epidemics—crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med. 1994;331(21):14221427. Crossref, MedlineGoogle Scholar
9. Edlin BR, Irwin KL, Ludwig DD, et al.. High-risk sexual behavior among young street-recruited crack cocaine smokers in three American cities: an interim report. The Multicenter Crack Cocaine and HIV Infection Study Team. J Psychoactive Drugs. 1992;24(4):363371. Crossref, MedlineGoogle Scholar
10. Des Jarlais D, Semaan S, Arasteh A. At 30 years: HIV and other STDs among persons who use psychoactive drugs. In: , Hall B, Hall J, Cockerell C, eds. HIV/AIDS in the Post-HAART Era: Manifestations, Treatment, and Epidemiology. Sudbury, MA: Jones and Barlett; 2011:753778. Google Scholar
11. Semaan S, Steele B, Des Jarlais D, Malow R. Methamphetamine Use and HIV Risk Behaviors Among Heterosexual Adolescents and Adults in the United States. In: XVI International AIDS Conference; 2006; Toronto, Canada. Google Scholar
12. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Yayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20(1):7383. Crossref, MedlineGoogle Scholar
13. Tobian A, Quinn T. Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Curr Opin HIV AIDS. 2009;4(4):294299. Crossref, MedlineGoogle Scholar
14. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185(1):4552. Crossref, MedlineGoogle Scholar
15. Des Jarlais D, Semaan S. HIV and other sexually transmitted infections in injection drug users and crack cocaine smokers. In: , Holmes K, Sparling P, Stamm W, Piot P, eds. Sexually Transmitted Diseases. New York: McGraw Hill; 2008:237255. Google Scholar
16. Des Jarlais D, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman S. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend. 2009;101(1–2):8891. Crossref, MedlineGoogle Scholar
17. Coates T, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372(9639):669684. Crossref, MedlineGoogle Scholar
18. Des Jarlais DC, Arasteh K, McKnight C, et al.. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend. 2010;109(1–3):154160. Crossref, MedlineGoogle Scholar
19. Donoghoe MC, Verster A, Pervilhac C, Williams P. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance. Int J Drug Policy. 2008;19(suppl 1):S5S14. Crossref, MedlineGoogle Scholar
20. Des Jarlais DC, Perlis T, Arasteh K, et al.. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95(8):14391444. LinkGoogle Scholar
21. Des Jarlais DC, Arasteh K, Perlis T, et al.. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS. 2007;21(2):231235. Crossref, MedlineGoogle Scholar
22. Des Jarlais DC, Friedman SR, Sotheran JL, et al.. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA. 1994;271(2):121127. Crossref, MedlineGoogle Scholar
23. Stimson GV, Des Jarlais DC, Ball A, eds. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London: UCL Press; 1998. CrossrefGoogle Scholar
24. Amon JJ, Garfein RS, Ahdieh-Grant L, et al.. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994–2004. Clin Infect Dis. 2008;46(12):18521858. Crossref, MedlineGoogle Scholar
25. Garfein RS, Sweartzendruber A, Ouellet LJ, et al.. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007;91(suppl 1):S4S17. Crossref, MedlineGoogle Scholar
26. Avila PC, Segal MR, Wong HH, Boushey HA, Fahy JV. Predictors of late asthmatic response. Logistic regression and classification tree analysis. Am J Public Health. 2000;161(6):20922095. Google Scholar
27. Lauby JL, Semaan S, O'Connell A, Person B, Vogel A. Factors related to self-efficacy for use of condoms and birth control among women at risk for HIV infection. Women Health. 2001;34(3):7191. Crossref, MedlineGoogle Scholar
28. Loh W, ed. Logistic Regression Tree Analysis. New York: Springer; 2006. CrossrefGoogle Scholar
29. Breiman L, Friedman J, Stone C, Olshen R. Classification and Regression Trees. New York: Chapman and Hall/CRC; 1984. Google Scholar
30. Hagan H, Scheinmann R, Des Jarlais DC, et al.. Meta-analysis of HIV/HCV co-infection in injecting drug users. In: National HIV Prevention Conference; 2006; Atlanta, GA. Google Scholar
31. Des Jarlais DC, Perlis T, Arasteh K, et al.. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS. 2005;19(suppl 3):S20S25. Crossref, MedlineGoogle Scholar
32. Semaan S, Des Jarlais D, Malow R. Sexually transmitted diseases among illicit drug users in the United States: the need for interventions. In: , Aral S, Douglas J, eds. Behavioral Interventions for Prevention and Control of Sexually Transmitted Diseases, Including HIV. New York: Springer-SBM; 2007:397430. CrossrefGoogle Scholar
33. Des Jarlais DC, Arasteh K, Perlis T, et al.. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction. 2007;102(5):778785. Crossref, MedlineGoogle Scholar
34. Frank B. An overview of heroin trends in New York City: past, present and future. Mt Sinai J Med. 2000;67(5–6):340346. MedlineGoogle Scholar
35. Des Jarlais DC, Arasteh K, McKnight C, et al.. Gender and age patterns in HSV-2 and HIV infection among non-injecting drug users in New York City. Sex Transm Dis. 2010;37(10):637643. MedlineGoogle Scholar
36. Neaigus A, Atillasoy A, Friedman SR, et al.. Trends in the non-injected use of heroin and factors associated with the transition to injecting. In: , Inciardi J, Harrison LD, eds. Heroin in the Age of Crack Cocaine. Thousand Oaks, CA: Sage; 1998:131159. Google Scholar
37. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins; 1998. Google Scholar
38. Greenland S. Meta-analysis. In: , Rothman K, Greenland S, eds. Modern Epidemiology. Philadelphia: Raven-Lippincott; 1998:643673. Google Scholar
39. Yu SZ, Zhao N. Combined analysis of case-control studies of smoking and lung cancer in China. Lung Cancer. 1996;14(suppl 1):S161S170. Crossref, MedlineGoogle Scholar
40. Hladik F, Hope TJ. HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep. 2009;6(1):2028. Crossref, MedlineGoogle Scholar
41. Kapiga SH, Sam NE, Bang H, et al.. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis. 2007;195(9):12601269. Crossref, MedlineGoogle Scholar
42. Des Jarlais DC, Marmor M, Friedmann P, et al.. HIV incidence among injecting drug users in New York City, 1992–1997: evidence for a declining epidemic. Am J Public Health. 2000;90(3):352359. LinkGoogle Scholar
43. Des Jarlais DC, Perlis T, Friedman SR, et al.. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990–1997. Am J Public Health. 2000;90(7):11121116. LinkGoogle Scholar
44. Des Jarlais DC, Perlis T, Friedman SR, et al.. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health. 1998;88(12):18011806. LinkGoogle Scholar

Related

No related items

TOOLS

SHARE

ARTICLE CITATION

Don C. Des Jarlais, PhD, Kamyar Arasteh, PhD, Courtney McKnight, MPH, Holly Hagan, PhD, David C. Perlman, MD, and Salaam Semaan, DrPH, MPHDon C. Des Jarlais, Kamyar Arasteh, Courtney McKnight, and David C. Perlman are with Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY. Holly Hagan is with New York University, School of Nursing, New York, NY. Salaam Semaan is with the Centers for Disease Control and Prevention, Atlanta, GA. “Associations Between Herpes Simplex Virus Type 2 and HCV With HIV Among Injecting Drug Users in New York City: The Current Importance of Sexual Transmission of HIV”, American Journal of Public Health 101, no. 7 (July 1, 2011): pp. 1277-1283.

https://doi.org/10.2105/AJPH.2011.300130

PMID: 21566021